Empresa Medovex Corp Nasdaq
Acciones
US58504H1014
Equipo médico y tecnología avanzada
Resumen de negocios
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -71,86 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -71,86 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 53 | 08/01/19 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 04/02/19 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 15/06/20 |
William E. Horne
BRD | Director/Board Member | 70 | 09/10/18 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 65 | 17/01/22 | |
Chief Executive Officer | 53 | 08/01/19 | |
William E. Horne
BRD | Director/Board Member | 70 | 09/10/18 |
Chairman | 77 | 08/01/19 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 17/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 712 710 | 253 876 ( 35,62 %) | 0 | 35,62 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+12,50 % | 229 mil M | |
+14,52 % | 195 mil M | |
+17,51 % | 142 mil M | |
+28,96 % | 109 mil M | |
+3,27 % | 64,85 mil M | |
+18,16 % | 54,33 mil M | |
+7,63 % | 52,09 mil M | |
+10,95 % | 45,15 mil M | |
+5,10 % | 37,39 mil M |